Search research articles
Contact Us
Filters
Showing results (191-200 of 271) with videos related to
Page
of 28
Sort By:
AIDS (London, England)
|
February 8, 2022
Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in South Africa
Lauren Jennings, Reuben N Robbins, Nadia Nguyen, et al.
AIDS Research and Human Retroviruses
|
May 24, 2019
Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project
Matthew A Spinelli, David V Glidden, Peter L Anderson, et al.
The Lancet. HIV
|
September 19, 2017
Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report
Elske Hoornenborg, Maria Prins, Roel C A Achterbergh, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
October 30, 2024
[Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort]
Mark A M van den Elshout, Eline S Wijstma, Anders Boyd, et al.
AIDS Research and Human Retroviruses
|
March 8, 2021
Short Communication: A Descriptive Analysis of Dried Blood Spot Adherence Testing Among Ugandans with HIV Presenting with Cryptococcal Meningitis
Sarah M Lofgren, Melanie R Nicol, Tadeo K Kandole, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 6, 2018
Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings
Craig J Hoesley, Beatrice A Chen, Peter L Anderson, et al.
The Journal of Infectious Diseases
|
May 3, 2024
Drug Concentrations in Hair and Dried Blood Spots as Preexposure Prophylaxis Adherence Metrics During Pregnancy and Postpartum
Linxuan Wu, John Kinuthia, Peter L Anderson, et al.
Biorxiv : the Preprint Server for Biology
|
June 8, 2021
Pharmacokinetics of Orally Administered GS-441524 in Dogs
Victoria C Yan, Cong-Dat Pham, Matthew J Yan, et al.
Antimicrobial Agents and Chemotherapy
|
October 18, 2017
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy
Peter L Anderson, Albert Y Liu, Jose R Castillo-Mancilla, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 28, 2023
Comparing Predictive Ability of Two Objective Adherence Measures in a Community-Based Cohort on Antiretroviral Therapy in South Africa: Tenofovir Diphosphate Concentrations and Electronic Adherence Monitors
Lauren Jennings, Christopher M Ferraris, Jose R Castillo-Mancilla, et al.
Page
of 28
Search research articles
Search
Showing results (191-200 of 271) with videos related to
Sort By:
Page
of 28
AIDS (London, England)
|
February 8, 2022
Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in South Africa
Lauren Jennings, Reuben N Robbins, Nadia Nguyen, et al.
AIDS Research and Human Retroviruses
|
May 24, 2019
Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project
Matthew A Spinelli, David V Glidden, Peter L Anderson, et al.
The Lancet. HIV
|
September 19, 2017
Acquisition of wild-type HIV-1 infection in a patient on pre-exposure prophylaxis with high intracellular concentrations of tenofovir diphosphate: a case report
Elske Hoornenborg, Maria Prins, Roel C A Achterbergh, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
October 30, 2024
[Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort]
Mark A M van den Elshout, Eline S Wijstma, Anders Boyd, et al.
AIDS Research and Human Retroviruses
|
March 8, 2021
Short Communication: A Descriptive Analysis of Dried Blood Spot Adherence Testing Among Ugandans with HIV Presenting with Cryptococcal Meningitis
Sarah M Lofgren, Melanie R Nicol, Tadeo K Kandole, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 6, 2018
Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings
Craig J Hoesley, Beatrice A Chen, Peter L Anderson, et al.
The Journal of Infectious Diseases
|
May 3, 2024
Drug Concentrations in Hair and Dried Blood Spots as Preexposure Prophylaxis Adherence Metrics During Pregnancy and Postpartum
Linxuan Wu, John Kinuthia, Peter L Anderson, et al.
Biorxiv : the Preprint Server for Biology
|
June 8, 2021
Pharmacokinetics of Orally Administered GS-441524 in Dogs
Victoria C Yan, Cong-Dat Pham, Matthew J Yan, et al.
Antimicrobial Agents and Chemotherapy
|
October 18, 2017
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy
Peter L Anderson, Albert Y Liu, Jose R Castillo-Mancilla, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 28, 2023
Comparing Predictive Ability of Two Objective Adherence Measures in a Community-Based Cohort on Antiretroviral Therapy in South Africa: Tenofovir Diphosphate Concentrations and Electronic Adherence Monitors
Lauren Jennings, Christopher M Ferraris, Jose R Castillo-Mancilla, et al.
Page
of 28